🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Status
Completed
Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
Start Date
2020-05-01
Trial ID
NCT05426148
The research objective is to evaluate the safety and tolerability of the in...
Status
Unknown
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2021-08-03
Trial ID
NCT06350058
Treatments Being Tested
Background: Despite the introduction of highly effective antiretroviral th...
Status
Completed
Location
Oslo University Hospital, Ullevål
Start Date
2012-09
Trial ID
NCT01627678
Treatments Being Tested
The primary purpose of this study is to evaluate safety/ reactogenicity of ...
Status
Completed
Location
Floridian Clinical Research LLC
Start Date
2023-05-17
Trial ID
NCT05901636
Treatments Being Tested
The purpose of the research is to evaluate the protective efficacy, immunog...
Status
Active Not Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2024-07-27
Trial ID
NCT06524947
The purpose of this study is to assess the safety and tolerability of 2 dif...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02304185
Treatments Being Tested
This study will evaluate the safety, tolerability, and immunogenicity of va...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-25
Trial ID
NCT01986010
The purpose of this study is to evaluate the safety and immune response to ...
Status
Completed
Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Start Date
2017-06-19
Trial ID
NCT03284710
This is a partially randomized, open-label phase 1 study to evaluate the sa...
Status
Recruiting
Location
Bridge HIV, San Francisco Department of Public Health
Start Date
2025-03-17
Trial ID
NCT06796686